References
- Results of a Dissolution Test Procedure Developed by FDA for Nitroglycerine Transdermal Delivery Systems. The 1988 United States Pharmacopeial Convention, Inc. Jan-Feb, 1988; 3458.
- Franz T. J. Percutaneous Absorption, on the Relevance of In Vitro Data. J. Invest. Dermatol. 1975; 64: 190
- Keshary P. R., Chien Y. W. Mechanisms of Transdermal Controlled Nitroglycerine Administration (I): Development of a Finite-Dosing Skin Permeation System, Drug Develop, and Ind. Pharm. 1984; 10(6)883
- Chien Y. W., Valia K. H. Development of a Dynamic Skin Permeation System for Long-Term Permeation Studies. Drug Develop. and Ind. Pharm. 1984; 10(4)575
- Bronaugh R. L., Stewart R. F. Methods of In Vitro Percutaneous Absorption Studies IV: The Flow-Through Diffusion Cell. J. Pharm. Sci. 1984; 74: 64
- Skelly J. P., Shah V. P., Maibach H. I., Guy R. H., Wester R. C., Flynn G., Yacobi A. FDA and AAPS Report of The Workshop on Principals and Practices of In Vitro Percutaneous Penetration Studies: Relevance to Bioavailability and Bioequivalence. Pharm. Res. 1987; 4: 265
- Shah V. P., Tymes N. W., Skelly J. P. Comparative In Vitro Release Profiles of Marketed Nitroglycerine Patches by Different Dissolution Methods. J. Control Release 1988; 7: 79
- Bronaugh R. L., Stewart R. F., Simon M. Methods of In Vitro Percutaneous Absorption Studies VII: Use of Excised Human Skin. J. Pharm. Sci. 1986; 75: 1094
- Keshary P. R., Chien Y. W. Mechanisms of Transdermal Controlled Nitroglycerine Administration (II): Assessment of Rate-Controlling Steps. Drug Develop, and Ind. Pharm. 1984; 10(10)1663